This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rome, IT (2008)
- Pomezia, IT (2012)
Company Filing History:
Years Active: 2008-2012
Title: Anna Maria Anastasi: Innovator in Antibody Development
Introduction
Anna Maria Anastasi is a prominent inventor based in Pomezia, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic applications. With a total of 2 patents, her work is recognized for its potential impact on cancer treatment and diagnostics.
Latest Patents
Among her latest patents is the "Anti-EpCAM antibody and uses thereof." This innovative antibody, designated ST3232/10, is of marine origin and exhibits properties suitable for both therapeutic and diagnostic applications. It shows high affinity for the native antigen and good tumor selectivity. Another notable patent is the "Anti-human tenascin monoclonal antibody." This novel anti-human tenascin ST2146 monoclonal antibody is endowed with high affinity for the native antigen and high tumor selectivity. The cST2146 hybridoma is stably producing the antibody in high-density culture conditions, making it suitable for the industrial development of ST2146-based products. ST2146 exhibits properties exploitable for both therapeutic and diagnostic applications.
Career Highlights
Anna Maria Anastasi is currently associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where she continues her research and development efforts. Her work has been instrumental in advancing the field of antibody therapeutics, and she is recognized for her innovative approaches to solving complex medical challenges.
Collaborations
Some of her notable coworkers include Rita De Santis and Fiorella Petronzelli, who have collaborated with her on various projects aimed at enhancing the efficacy of antibody-based treatments.
Conclusion
Anna Maria Anastasi's contributions to the field of biotechnology, particularly in antibody development, highlight her role as an influential inventor. Her patents reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile